Clinical Trial Update: Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of ALXN1920 in adults with primary membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• ALXN1920

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Primary Membranous Nephropathy | Phase 2 | Status: RECRUITING